PTCCO2 Monitoring During Retroperitoneoscopic Urologic Surgery
- Conditions
- Transcutaneous Carbon Dioxide Partial Pressure MonitoringRetroperitoneoscopic Urologic Surgery
- Registration Number
- NCT03226041
- Brief Summary
To investigate the accuracy and correlation of estimating arterial CO2 pressure(PaCO2) using a transcutaneous CO2 pressure(PTCCO2) monitor in patients undergoing retroperitoneoscopic renal or adrenal surgery.
- Detailed Description
30 patients undergoing retroperitoneoscopic renal or adrenal surgery were included in this study.Their PaCO2, PetCO2, and PTCCO2values were measured at 3 time points before and 30min, 60min after pneumoperitoneum and calculated the different between each measure(PetCO2 and PTCCO2) and PaCO2. Agreement among measures was assessed by the Bland-Altman method.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
- patients undergoing retroperitoneoscopic renal or adrenal surgery
- Age more than 16 years.
- Care taker unable or unwilling to give oral informed consent
- Patients with history of severe trauma, operations, smoking, and severe cardiovascular or respiratory diseases, such as coronary heart disease, congestive heart failure, or chronic obstructive pulmonary disease
4.Subject has a condition or allergy which would prohibit placing the probe 5.Subject has participated in a trial with any experimental drug or device trial within 30 days prior to enrollment in the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Bias and precision of the transcutaneous carbon dioxide measurements 60 minutes correlation and agreement between PetCO2 and PaCO2 and PTCCO2
- Secondary Outcome Measures
Name Time Method complication: appearance of signs of thermal injury (redness, skin erythema, blisters, necrosis) under application of transcutaneous sensor temperatures of 44°C ) 60 minutes While the sensor temperatures heated to 44°C, the skin will be closely observed for any kind of thermic tissue damage
Trial Locations
- Locations (1)
The First Affiliated Hospital of Nanjing Medical University
🇨🇳Nanjing, Jiangsu, China
The First Affiliated Hospital of Nanjing Medical University🇨🇳Nanjing, Jiangsu, China